Literature DB >> 15190537

Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure.

Karen E Joynt1, David J Whellan, Christopher M O'connor.   

Abstract

BACKGROUND: Depression is 4 to 5 times as common in heart failure (HF) patients as in the general population, might confer a higher risk of developing HF, and negatively affects prognosis in established HF. METHODS AND
RESULTS: A review was undertaken via Medline (1966-2003) and PsycINFO (1872-2003) searches using the subject headings "depressive disorder" and "heart failure, congestive." Our findings suggest that the link between depression and HF may be due to shared pathophysiology. Depression may augment catecholamine release, arrhythmias, elaboration of proinflammatory cytokines, and platelet activation--processes that may influence prognosis in HF. Depression is also associated with a higher risk of noncompliance and lower levels of social support, which have been shown to worsen prognosis in HF. The impact of pharmacologic or behavioral treatment for depression on physiologic parameters or clinical outcomes in HF remains unclear. Inherent difficulties in recognition of depression in the setting of HF may decrease the likelihood that depressed patients receive the treatment they need.
CONCLUSIONS: Depression is common in HF, may contribute to the development of HF in susceptible populations, and is independently predictive of poor clinical outcomes. Pathophysiologic pathways and psychosocial issues that are shared between the 2 conditions might explain these observations and represent potential therapeutic targets. Vigilant attention to the recognition and treatment of depression in HF patients is warranted.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15190537     DOI: 10.1016/j.cardfail.2003.09.008

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  41 in total

Review 1.  Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults.

Authors:  Susan E Hardy
Journal:  Am J Geriatr Pharmacother       Date:  2009-02

2.  Late-life depression and cardiovascular disease burden: examination of reciprocal relationship.

Authors:  Namkee G Choi; Jinseok Kim; C Nathan Marti; G John Chen
Journal:  Am J Geriatr Psychiatry       Date:  2014-04-19       Impact factor: 4.105

3.  Executive dysfunction and depressive symptoms associated with reduced participation of people with severe congestive heart failure.

Authors:  Erin R Foster; Kathleen B Cunnane; Dorothy F Edwards; M Tracy Morrison; Gregory A Ewald; Edward M Geltman; Allyson R Zazulia
Journal:  Am J Occup Ther       Date:  2011 May-Jun

4.  Combined exercise and cognitive behavioral therapy improves outcomes in patients with heart failure.

Authors:  Rebecca A Gary; Sandra B Dunbar; Melinda K Higgins; Dominique L Musselman; Andrew L Smith
Journal:  J Psychosom Res       Date:  2010-03-12       Impact factor: 3.006

5.  Predictors of re-hospitalization in patients with chronic heart failure.

Authors:  Melody Zaya; Anita Phan; Ernst R Schwarz
Journal:  World J Cardiol       Date:  2012-02-26

6.  Depression and cardiovascular disease: healing the broken-hearted.

Authors:  Mary A Whooley
Journal:  JAMA       Date:  2006-06-28       Impact factor: 56.272

7.  Adherence to the low-sodium diet plays a role in the interaction between depressive symptoms and prognosis in patients with heart failure.

Authors:  Eun Kyeung Song
Journal:  J Cardiovasc Nurs       Date:  2009 Jul-Aug       Impact factor: 2.083

8.  The impact of medication nonadherence on the relationship between mortality risk and depression in heart failure.

Authors:  Emily C Gathright; Mary A Dolansky; John Gunstad; Joseph D Redle; Richard A Josephson; Shirley M Moore; Joel W Hughes
Journal:  Health Psychol       Date:  2017-07-20       Impact factor: 4.267

9.  Risk factors for rehospitalization in heart failure with preserved ejection fraction compared with reduced ejection fraction.

Authors:  Masahiko Setoguchi; Yuji Hashimoto; Taro Sasaoka; Takashi Ashikaga; Mitsuaki Isobe
Journal:  Heart Vessels       Date:  2014-06-17       Impact factor: 2.037

10.  Experiences of a community pharmacy service to support adherence and self-management in chronic heart failure.

Authors:  Richard Lowrie; Lina Johansson; Paul Forsyth; Stuart Lochhead Bryce; Susan McKellar; Niamh Fitzgerald
Journal:  Int J Clin Pharm       Date:  2013-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.